Sepsis-associated encephalopathy: Autophagy and miRNAs regulate microglial activation

Nannan Qin1, Yanmei Miao1, Leiyu Xie1

  • 1Department of Critical Care Medicine of the Third Affiliated Hospital (The First People's Hospital of Zunyi), Zunyi Medical University, Zunyi, China.

Physiological Reports
|March 5, 2024
PubMed

Insights

Sepsis-associated encephalopathy (SAE) involves brain dysfunction due to sepsis-induced inflammation. Activated microglia drive neuroinflammation in SAE, highlighting them as potential therapeutic targets.

Area of Science:

  • Neuroscience
  • Immunology
  • Critical Care Medicine

Background:

  • Sepsis-associated encephalopathy (SAE) is a common neurological complication in intensive care units, characterized by brain dysfunction resulting from the systemic inflammatory response to sepsis.
  • Microglia, the resident immune cells of the central nervous system, play a crucial role in maintaining brain homeostasis through phagocytosis.
  • Dysregulated microglial activation and the subsequent neuroinflammatory response are implicated in the pathogenesis of various central nervous system diseases, including SAE.

Purpose of the Study:

  • To systematically review the functions and phenotypes of microglia in the context of SAE.
  • To elucidate the mechanisms by which microglia-mediated neuroinflammation contributes to the development and progression of SAE.
  • To discuss recent advancements in targeting microglial activation via autophagy and microRNA pathways for potential SAE therapeutic strategies.

Main Methods:

  • Systematic literature review and synthesis of existing research on microglia, neuroinflammation, and SAE.
  • Analysis of microglial functions, phenotypes, and their role in SAE pathogenesis.
  • Review of current research on autophagy- and microRNA-mediated regulation of microglial activation.

Main Results:

  • Microglia activation is central to the neuroinflammatory processes underlying SAE.
  • Specific microglial phenotypes and their interactions with neuronal cells contribute to brain dysfunction in sepsis.
  • Autophagy and microRNA pathways represent promising avenues for modulating microglial activity in SAE.

Conclusions:

  • Microglia-mediated neuroinflammation is a key driver of SAE.
  • Understanding microglial behavior and regulatory pathways is crucial for developing effective SAE treatments.
  • Targeting microglial activation holds potential for novel therapeutic interventions for SAE.